Iodothyronine deiodinases (Dios) are important selenoproteins that control the concentration of the active thyroid hormone (TH) triiodothyronine through regioselective deiodination. The X-ray structure of a truncated monomer of Type III Dio (Dio3), which deiodinates TH inner rings through a selenocysteine (Sec) residue, revealed a thioredoxin-fold catalytic domain supplemented with an unstructured Ω-loop. Loop dynamics are driven by interactions of the conserved Trp207 with solvent in multi-microsecond molecular dynamics simulations of the Dio3 thioredoxin(Trx)-fold domain. Hydrogen bonding interactions of Glu200 with residues conserved across the Dio family anchor the loop’s N-terminus to the active site Ser-Cys-Thr-Sec sequence. A key long-lived loop conformation coincides with the opening of a cryptic pocket that accommodates thyroxine (T4) through an I⋯Se halogen bond to Sec170 and the amino acid group with a polar cleft. The Dio3-T4 complex is stabilized by an I⋯O halogen bond between an outer ring iodine and Asp211, consistent with Dio3 selectivity for inner ring deiodination. Non-conservation of residues, such as Asp211, in other Dio types in the flexible portion of the loop sequence suggests a mechanism for regioselectivity through Dio type-specific loop conformations. Cys168 is proposed to attack the selenenyl iodide intermediate to regenerate Dio3 based upon structural comparison with related Trx-fold proteins.
Iodothyronine deiodinase (Dio) membrane selenoproteins regulate thyroid hormone (TH) activity through regioselective deiodination (Fig. 1a)1,2,3,4,5,6,7,8,9,10. The thyroid gland primarily produces the prohormone thyroxine (3,3′,5,5′-tetraiodothyronine, T4), which is distributed to peripheral tissues for outer ring deiodination (ORD) to the active TH 3,3′,5-triiodothyronine (T3) by Type II (Dio2)3,11. Type III (Dio3) maintains TH homeostasis by removing iodine from the inner ring (IRD) of T4 or T3 to produce inactive reverse-T3 (3,3′,5′-triiodothyronine, rT3) or 3,3′-diiodothyronine (3,3′-T2), respectively5,6,12. Type I (Dio1) deiodinates either ring, but prefers ORD1. Structural studies of Dio are challenging due to the difficulty of isolating membrane proteins13. By removing the N-terminal transmembrane region, Schweizer et al. solved the first structure of the catalytic domain of mus Dio314. The thioredoxin(Trx)-fold motif of the monomer was shown to be supplemented with an N-terminal β1 extension related to peroxiredoxins (Prx) and a Dio-insertion region between β2 and α2 (Fig. 1b)14,15. The characteristic CXXC active site motif at the β1α1 turn of Trx-fold proteins is modified to Ser-Cys-Thr-Sec (SCTU), incorporating a highly nucleophilic selenocysteine (Sec, U)16,17.
The Dio deiodination mechanism involves an initial I⋯Se halogen bonded (XB) intermediate complex of Sec170 and the TH substrate (Fig. 1c)18,19,20,21,22. From this intermediate, the protein facilitates protonation of the carbanionic leaving group for an overall nucleophilic attack of selenolate on the C–I bond. The selenenyl iodide (-SeI) intermediate reacts with an internal resolving Cys to a selenosulfide and Dio is regenerated through reduction by dithiothreitol in vitro or an endogenous thiol cofactor23. Endocrine disrupting halogenated aromatic compounds such as polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs) could inhibit Dio by forming a X⋯Se complex that blocks TH access to Sec24,25,26. Although XB interactions differ in strength for inner and outer-ring iodines when calculated by density functional theory (DFT)24,27, the regioselectivity of deiodination (IRD vs ORD) must be controlled by interactions between the substrate and active site residues24. However, no direct structural information is available for a TH or inhibitor complex with Dio that would demonstrate how individual Dio types control selectivity.
The X-ray structure for the catalytic domain of the mus Dio3 monomer shows an unstructured β2αD-loop (loop-D) adjacent to the active site within the Dio-insertion site14. Extended loops of 19–23 amino acids are a common feature of Dio proteins. Ω-loops, first described by Fetrow (Lezsczynski) et al., are irregular secondary protein structural motifs28,29,30 that lack repeating backbone dihedral or hydrogen bonding patterns28. These features are commonly found on the exterior of proteins, suggesting a role in substrate binding, catalytic activity, or protein stability28,29. Loop-D of mus Dio3 (residues 201–217: AHPSDGWVTTDSPYVIP) contains residues (e.g., Pro, Asp, and Gly) and other structural features common to Ω-like loops, such as sequence length; lack of regular secondary structure; and a short Cα–Cα distance between the segment termini (3.7–10.0 Å)28,30. While the Trx-fold and the N-terminal AHxxDGW sequence of the β2αD loop is conserved across the Dio family, the length and sequence of the Ω-loop varies significantly while maintaining high similarity within types (Fig. 1d) suggesting a potential contribution to Dio regioselectivity. Of this sequence, His202 (corresponding to His162 for Dio2 and His158 for Dio1 in Mus musculus) was proposed to bind the 4′-phenol of THs14, but the role of other conserved residues have not been established. The constriction point of the Ω-loop is a hydrogen bonding interaction between Ser204 NH and Ile216 CO (d(Cα–Cα) = 5.26 Å).
Multi-microsecond molecular dynamics (MD) simulations of the monomer of the Dio3 Trx-fold domain identify a key conformation the Ω-loop that coincides with the opening of a cryptic pocket to the active site Sec170. In simulations with T4 docked to this pocket and modelled with a strong inner-ring I⋯Se interaction, substrate binding is supplemented by a I⋯O interaction between an outer-ring iodine and the Asp211 loop residue, consistent with the regioselectivity of Dio3. Hydrogen bonding interactions and packing of nonpolar groups such as Trp207 into the interior of the loop contribute to the conformation dynamics of the loop. Extending this understanding of the role of the Ω-loop and XB interactions to Dio3-T4 binding to both the mechanism and selectivity could lead to development of targeted treatments for thyroid hormone-related disease.
Conformation dynamics in Dio3trunc
MD simulations of the Trx-fold region of monomeric Dio3 were performed for 20 μs starting from the X-ray structure A (PDB: 4TR4)14 truncated to Gly132 (Dio3trunc). The Ω-loop conformation of A is found to be unstable because the nonpolar sidechains (i.e., Trp207, Val215, Pro217) on the exterior loop surface reorganize in search of a more favourable solution-phase conformation. The structure of the Trx-fold is generally constant during simulations with significant fluctuations found in the β2αD Ω-loop which adopts three long-lived conformations (B–D, Fig. 2 and S1). These results are consistent with normal mode analysis31 of the X-ray structure which indicates that the motion of the active site SCTU sequence and the Ω-loop are slightly correlated (See Supporting Information).
Statistical analysis was used to map residues with fast motion relative to the protein's global dynamics by determining pairwise contact events and backbone hinge motions (Fig. 2)32,33. Median filtering of the root-mean-square (RMS) fluctuations reflects the random distribution of events within the bulk of the Trx fold of Dio3trunc over the course of the trajectory (Fig. 2a). Distance cutoff and generalized masked Delaunay (GMD) buffer regions select for significant events, such as the reversible C–D transitions, while screening out trivial events (Fig. 2a)32,33. Most pairwise contact events involve the residues of the Ω-loop, especially the conserved Trp207 (Figs. 2b, S3). The magnitude of the activity within RMS fluctuation (RMSF) mapping is consistent with the raw Cα RMSF (Fig S1b). Other regions with significant contact event activity are also found at the flexible βN1βN2, θ1β1, and αDβD turns.
Separate analysis of a culled trajectory of Ω-loop residues 201–210 (Fig. 2d–f) shows that the highest portion of events occur within the transition regions between conformations with a sharp increase at the C–D conformation changes. Hinge-bending motions are prevalent for the pivot angles of residues between the Ser204-Ile216 constriction point (Fig. S3). Several angles are constant for long-lived conformations, yet highly flexible in the transition regions, especially between B and C (Fig. S4). The hinge pivot activity may be driven by backbone rearrangements necessary to accommodate hydrogen bonding interactions characteristic of conformations B–D (e.g., involving Pro 203, Ser204, and Ser212, Fig. S5) which are formed and broken over the course of the simulation. The contributions of hydrogen bonding to the conformation dynamics and lower event activity detected in regions populated by B–D is consistent with characterization of the Ω-loop as static34,35. The high variability of the hinge angles in the transition regions and the reversible C–D conformation change suggests C as a key loop conformation for Dio3 activity, which is supported by the locking of this conformation by T4 binding (vide infra).
Structural features of the Ω-loop region
Glu200 anchors the Ω-loop to the Dio3 active site (Fig. 3a) through an extended hydrogen bonding network that include conserved residues at the SCTU motif and C- and N-termini of the Ω-loop. Previously, Glu200 with His219 and Ser167 were proposed to participate in the proton cascade system that facilitates deiodination (Fig. 1c)14,18,36. In A, the extended Glu200 hydrogen bonding network links interactions between the Cys168 backbone (BB) NH and the sidechain (SC) of Tyr197, His202 NHBB and Thr169 SC, and Arg225 NHSC and His219 Nε (Fig. 3a). This latter interaction secures the loop C-terminus to αD. Most of these interactions remain largely intact throughout the simulation with the following changes and additions to the network maintained in B and C (Fig. 3). For example, the Tyr197 phenol shifts from Cys168 NH to interact with His219 NδH. Cys168 NH becomes part of the Glu200 anchor sharing the carboxylate with interactions to the Thr169 NHBB and SC. The Gln218 SC also rotates to interact with the BB CO and NH of Glu200. Mutation of selected residues within this network significantly decreases experimental Dio activity (i.e., Glu200Ala, Thr169Ala, Ser167Ala)14.
Structural comparison of the principle Ω-loop conformations suggests that increasing exposure of polar sidechains to the solvent environment drives the initial conformation change from the X-ray structure A to B. The middle segment of the Ω-loop becomes pinched by several hydrogen bonds (i.e., Ser204-Ser212 SC-SC and Gly206-Thr209 BB-BB). A cross-loop SC-BB interaction in A between Asp205 and the Gln218 NH weakens as the Gln218 SC rotates to hydrogen bond with Glu200 BB CO. The Phe258 SC, which blocks access to Sec170 in A, rotates in and out of occlusion of Sec170 during the simulation. However, the shallow pocket to Sec170 is not well-suited for substrate binding as docking of T4 to B does not lead to a bound conformation.
Several key hydrogen bonding interactions that define B (i.e., Gly206–Thr209 BB–BB and Ser204–Ser212 SC–SC, Fig. S5 and Table S1) are lost after 2 μs as the loop undergoes an extended period of significant rearrangement. At 12 μs, the loop adopts the long-lived conformation C in which BB–BB bridging of the Asp211 and Ser212 NHs by Val208 CO replaces the Ser204–Ser212 SC–SC interaction characteristic of B. Similarly, the Pro203 CO spans the Gly206 and Trp207 NHBBs, limiting the mobility of the Gly206–Trp207 hinge pivot (Fig. S4). Most significantly, at C the Trp207 indole folds into a nonpolar cleft between Pro203 and Gly206 (Figs. 3c, 4a). Protrusion of Trp207 into the solvent is the primary contributor to conformational instability as indicated by the pair contact and hinge-pivoting fast motions (Fig. S3) and normal mode analysis (Fig. S7). Trp207 is conserved in all Dio types and its hydrophobic properties may contribute to substrate selectivity through control of the loop conformation. An Ω-loop Trp also contributes to the active site gating mechanism of acetylcholinesterase37. Conformation C undergoes a reversible change to D as the His202–Trp207 π-stacking interaction is lost and constriction point drifts to a Ser204–Val215 BB–BB interaction. D consists of two closely related conformations in which the active site is partially occluded by Tyr197 due to a loop C-terminus conformation change that moves His219 to the exterior of the protein.
Formation of a cryptic pocket
Rearrangement to C coincides with the opening of a narrow cryptic pocket to Sec170 observable in the Dio3trunc electrostatic potential (Fig. 3d–f). The pocket accommodates TH substrate binding through both an inner ring TH-Sec170 I⋯Se XB interaction and electrostatic interactions between the amino acid group and a polar cleft. Sec is partially buried in the pocket, protecting it from cellular oxidants. Phe258 forms a hydrophobic wall with Tyr257 and Ala201 near Sec170 (Fig. 4d). The reduced activity of the Phe258Pro and Tyr257Ala mutations14 could be attributed to conformational restrictions that prevent effective pocket formation. Arg176 salt-bridges Asp278 and Glu259 to form the opposite wall and floor of the pocket, respectively. Arg176 replacement by Lys and Asn in mus Dio1 and Dio2, respectively, may alter the pocket topology to affect selectivity. Pro171 and 172 abut the Arg176–Asp278 salt bridge and introduces a kink in α1 toward the Sec170 end of the pocket. On the same side, Gly276 and Pro277 interact with Arg275 for the wall near the polar cleft. The loop end of the pocket consists of a π-stacking interaction between His202 and Trp207, the latter of which remains tucked into the nonpolar Pro203–Gly206 cleft. The sidechains of Tyr257 and Arg275 face into the polar end of the pocket and are reinforced by Arg260 which also hydrogen bonds to the Tyr280 SC and Gly274 BB. Arg275 lies in the slow34, flexible β4α3 turn close to a proposed dimerization interface14 and opens and closes over this polar cleft as a possible gating mechanism for binding of the amino acid end of T4. Dimer formation at the α3β4 edge may dampen the motion of the turn contributing to a stronger interaction with the polar cleft relative to the monomer.
Substrate binding to the cryptic pocket
Simulations were performed with T4 docked to the active site of conformations A–D assuming the formation of the initial inner-ring I⋯Se XB intermediate along the path to deiodination (Fig. 4)18. Dio3trunc-T4 complexes were equilibrated using a force field that treats the strong I⋯Se XB as a covalent bond with the XB charge distribution adapted from DFT model complexes24. All other iodines use charged dummy atom method of Jorgensen and Schyman38 to represent σ-holes39 along the C–I bond axes. This approach constrains T4 to the active site during the equilibration process while allowing weak intermittent electrostatic XB interactions between the ancillary iodines and the solvent or protein. Simulations with T4 docked to A (with Phe258 rotated to expose Sec170), B, or D did not result in stable Dio3trunc-T4 complexes because these conformations lack well-defined active site pockets. The cryptic pocket of C accommodates both the I⋯Se XB interaction and the T4 amino acid group in the cleft near Arg275 (Fig. 4d). Over a 4-μs simulation, the Ω-loop conformation is constant (Fig. 4b,c), and T4 remains bound to the pocket with minor structural changes, specifically a shift of the constriction point of the loop from Ser204–Ile216 BB–BB to SC–BB. Gln218 SC reinforces this shift through a hydrogen bond network with His202 BB and Ser204 SC. Hydrogen bonding interactions to the Arg275 and Tyr257 SC hold the T4 carboxylate in the cleft. The lack of a full salt bridge to the T4 carboxylate may contribute to the low activity of the Arg275Ala mutant14. Both Ala276 BB groups also stabilize the T4 amino acid group in the cleft.
Following a brief equilibration period, an I⋯O halogen bond forms between the outer-ring T4 iodine and Asp211 carboxylate with the loop locked in a slightly modified conformation C (Fig. 4b,c). The non-bonding I⋯O interaction is held in place by the electrostatic interaction between the Asp211 carboxylate and the positively charged dummy atom representing the outer-ring σ-hole of T438. The other outer-ring iodine lies in a hydrophobic cleft created by the Ala201 and Phe258 sidechains and forms intermittent weak electrostatic XB interactions with solvent water.
The I⋯O interaction alternates between the oxygen centres of the sidechain with distances in the 3.0–3.5 range and ∠ C–I⋯O of between 165° and 180°, consistent with known I⋯O XB interactions (Figs. 4c, S6)40,41. The positioning of Asp211 is reinforced by hydrogen bonding to the Trp207 indole and a turn in the loop induced by a bifurcated BB-BB interaction between Val208 CO and Asp211 and Ser212 (Figs. 3b, 4a). Similar XB interactions are found for the interaction of Asp with the heme-bound 4-iodopyrzole in nitrophorin (3.30 Å, PDB 1ML7)42 and iodipamide in human serum albumin (3.48 Å, PDB 2BXN)43. The I⋯O interaction in the latter is supported by a Lys-Asp salt bridge similar to the Trp207-Asp211 interaction in Dio3trunc. Sulfation of the T4 phenol prevents Dio3 activity44, possibly due to inhibition of binding by repulsions with Asp211.
The presence of the secondary I⋯O XB interaction with the protein is consistent with the high affinity of Dio3 for T3, and its primary function of controlling plasma T3 levels through deactivation to 3,3′-T22. Asp211 is conserved across species in Dio3, but not in Dio1 and Dio2. (Asp occurs one residue downstream in Dio1 for some species, but it is not conserved.) The secondary interaction also suggests a potential for lower Dio3 affinity for THs without outer-ring iodines (i.e., 3,5-T2 and 3-T1). PCBs or PBDEs having an ortho halogen on one ring and a meta on the other could be effective inhibitors of Dio3 due to their ability to reinforce the primary X⋯Se XB interaction with the secondary X⋯O interaction. Similar structural features may define the selectivity of Dio1 and Dio2, discovery of which may aid the design specific inhibitors for each Dio type.
His158 and His174 (analogous to His202 and His219 in Dio3, respectively) were shown to be important for rattus Dio1 activity45. Mutation of His158 in Dio1 results in a complete loss of activity. His202 was proposed to act with Arg275 to clamp TH into the active site by a hydrogen-bonding interaction with the 4′-OH group in analogy to the T3-bound receptor β14,46. In the current simulations, protonated His202 is sandwiched between the T4 outer ring and Sec170. Simulations of His202 in the deprotonated state show no interaction with the phenol and loss of T4 binding to the pocket. His174 is conserved for mus Dio1-3, but Arg275 in Dio3 is not. Dio1 has Arg one residue earlier in its sequence than Dio3 and Dio2 replaces Arg with Lys. These observations could suggest a cooperative interaction between His and Arg/Lys that, along with the differing Ω-loop sequences in Dio1-3, may contribute to regioselectivity. Alternatively, His202 may have a different role in Dio activity, such as enhancing Sec170 nucleophilicity deprotonation47. Simulations indicate that His219 in Dio3trunc plays a structural role through an extended hydrogen bonding network with Arg225 and Tyr197. Loss of Arg225-His219 interaction in region D contributes to the collapse of the cryptic pocket which agrees with the proposed importance of its Dio1 analogue His174 for substrate binding, rather than catalysis45. Mutation to Gln or Asn, which can maintain similar hydrogen bonding interactions to His, increase KM with no effect on Vmax45.
MD simulations of the T4-Dio3trunc complex indicate that water molecules in the binding pocket likely to act as proton donors for the carbanion formed by deiodination. These waters lie primarily on the Arg176 side of the cryptic pocket and bridge the −NH3+ group of the T4 amino to the carbon of the inner-ring C−I bond activated by the I⋯Se XB (Fig. 4d). Several other water molecules seep into the cryptic pocket to hydrate the selenolate of Sec170. A water also bridges the sidechains of Ser167 and Thr169. Based upon the X-ray structure, Ser167 was assigned as the proton donor for nucleophilic deiodination and mutation to Ala reduces activity by > 90%14. However, in simulations, this residue lies on the opposite side of the Phe258-containing hydrophobic wall of the cryptic pocket from T4 where its alcohol group cannot contact the substrate.
Mutations to Ω-loops are known to destabilize protein structure28. The formally disordered Dio3 Ω-loop contributes to substrate selectivity through rigid conformations that position Asp211 for stabilization of T4 binding and enhanced selectivity for IRD. Mutations of the residues responsible for these rigid conformations will result in loss of the required conformation for TH binding and reduced activity. Several Dio3 mutants (Glu200Thr, Tyr197Phe and Thr169Ala14) in the region that anchors the C-terminus of the Ω-loop to the active site completely deactivate the protein. Although Glu200 was proposed to participate in the proton exchange network critical for catalytic deiodination14,18, in simulations it serves as the central residue of the conserved anchor region, forming interactions with Thr169 and Tyr197 that limit the flexibility of the Ω-loop. Mutation of the analogous Glu in human Dio1-3 to Ala results in inactive proteins15 because the unconstrained loop cannot form conformations necessary for substrate binding. In contrast, Glu200Asp maintains the ability to form this central hydrogen bonding network and either increases KM or has no effect on activity14. A Thr169Ser mutation reduces the activity by only 60% because the protein can maintain the connectivity of the Glu200 anchor region14. The void created by the missing methyl group impacts the packing of hydrophobic sidechains (i.e. Ile216) in the loop and alters the orientation of Asp211 for a negative effect on substrate binding.
Regeneration of the selenolate by reduction of the selenenyl iodine is presumed to proceed through a selenosulfide intermediate. Internal Sec170-Cys239 selenosulfide bond formation was proposed14 in analogy to PtGPX5, an atypical 2-Cys peroxiredoxin (Prx), where a Cys44-Cys92 disulfide bond is observed in the oxidized protein (PDB: 2P5R48). The peroxidic Sec170 and Cys44 residues are similarly located in Dio3 and PtGPX5 (BLAST sequence similarity 17%), respectively. However, Cys92 is located in the equivalent of αD, where Cys239 is downstream in the αDβD loop. Both residues are distant from the active site (22.3 and 16.0 Å, resp.). Cys44-Cys92 disulfide bond formation in PtGPX5 requires unravelling of the αD helix facilitated by repulsions between Cys92 and two acidic residues, Asp85 and Asp89, positioned at the helix turns48. A similarly-located unstable helix without destabilizing acidic residues in E. coli thiol peroxidase (PDB: 3HVV) positions the resolving Cys on the interior of the protein closer (~ 11.5 Å) to the peroxidic Cys49. In contrast, Dio3 αD lacks residues to induce helix-coil transitions and its residues do not fluctuate significantly in simulations, although the αDβD turn itself is moderately flexible (Figs. S1, S3).
In Dio1 and Dio3, the upstream Cys of the SCTU motif may resolve the selenenyl iodide by a similar mechanism to active site CXXC motifs in redox Trx-fold proteins17. For example, cytochrome maturation proteins and thiol peroxidases, which are structurally similar to Prx and Dio, have CXXC motifs that form cyclic disulfides (i.e., PDB 1KNG50, Fig. 4e)51. The VCTU motif at the β1α1 turn of Drosophila Sep15 (PDB: 2A4H), a Trx-fold selenoprotein, also contains a disulfide bond in the Cys mutant52. In Dio3, both Cys lie within a channel with access to Sec170, but Cys168 is closer to Sec170 (in C, d(SeSec⋯SCys) ≈ 8 Å compared to 17 Å for Cys239), nucleophilic attack by Cys168 would require minimal rearrangement of the β1–α1 loop, and the greater reactivity of Sec favors reaction on a shorter timescale than helix unfolding. Studies show lower activity for the Cys168Ala mutant14, but no change for Cys239Ala, suggesting the former is more critical for turnover. Dio2, which is missing the active site Cys yet retains the analog of Cys239, deiodinates one equivalent of T4 and is tagged for destruction by ubiquitin53,54. The SATU motif in Dio2 may trap Sec in an intermediate susceptible to ubiquitin tagging that cannot be resolved without the assistance of the active site Cys. Alternatively, Cys239 could be positioned to attack the Cys168 end of the selenosulfide to release the selenolate and form a Cys168-Cy239 bond as observed in PtGPX5. Similarly, Cys73 in PtGPX5 has a shorter pathway to Cys44 (d(S⋯S) = 11.5 Å versus 22.3 Å for Cys92) and would require less rearrangement to attack Cys44. An initial Cys44-73 disulfide bond could induce the helix–coil transition with subsequent thiol-disulfide exchange to Cys44-Cys92. Regardless of which Cys in Dio3 is resolving, the large distances to Sec170 preclude a deiodination mechanism assisted by a Se⋯S chalcogen bonding interaction as proposed for naphthalene-based Dio mimics21.
The two residues following Sec appear to define the overall kinetics of deiodination. A Pro-Pro sequence in Dio2 and Dio3 correspond to the ping-pong kinetics, whereas Pro-Ser in Dio1 corresponds to sequential kinetics and inhibition by propylthiouracil (PTU)14. Mutation of Pro135 in Dio2, analogous to Pro172, to Ser changes the enzyme kinetics of deiodination from ping-pong to sequential15. Mutation of the Pro-Pro sequence to Pro-Ser allows PTU to target Dio2 and Dio3. Dio1 in some fish species contain the PP sequence and are also PTU insensitive7. The second residue may be important for rearrangements needed to resolve the -SeI intermediate14. Because PTU is unreactive toward selenium functional groups in their most reduced states, Sec170 must first be formally oxidized by deiodination of T4. It is not clear whether PTU attacks the selenenyl iodide or the selenosulfide. In the selenenyl iodide state, Sec170 is protected by the bulk of the protein and the rigidity of the Pro-Pro sequence. Rapid resolution of -SeI by Cys168 releases iodide such that PTU could access Sec170 by the cryptic pocket. The Pro-Pro sequence may block Sec170 where Pro-Ser could induce a conformation change with an open pocket.
Experimental study of substrate binding to the iodothyronine deiodinase (Dio) family is challenging because these membrane-bound selenoproteins are difficult to isolate. Molecular dynamics simulations of the Type III Dio (Dio3) monomer provide atomistic insight into the possible mechanism for substrate binding and regioselectivity for the activation and control of the cellular thyroid hormone concentration. Thyroxine binding is found to depend upon the conformation of a Dio-specific Ω-loop and the opening of a cryptic pocket. This flexible loop is adjacent to Sec170 and rearranges from the X-ray structure to minimize solvent interactions with nonpolar residues. Multi-microsecond simulations were required to fold the conserved Trp207 into a hydrophobic cleft to populate a key loop conformation. Opening of a cryptic pocket in conjunction with this loop conformation allows thyroxine binding through a polar cleft for the amino acid group and an I⋯Se inner-ring halogen bond to Sec170. Thyroxine binding to the pocket is stabilized by an I⋯O halogen bonding interaction between the σ-hole of an outer ring iodine and the Asp211 carboxylate. Protonation of the carbanion leaving group during deiodination is facilitated by water molecules in the pocket.
Additional features identified by MD simulations provide an alternate perspective on the overall Dio3 mechanism. The location of Cys168 in the SCTU motif is consistent with a backside attack on the selenenyl iodide to a cyclic selenosulfide found in the X-ray structures of oxidized Trx-fold proteins such as CcmG and Cys mutant of the Sep15 selenoprotein. Cys239 is too distant from Sec170 to directly resolve the selenenyl iodide. The αD helix near Cys239 is rigid and lacks destabilizing residues that induce unravelling of the analogous helix in PtGPX5.
The residues that make up the anchor region around Glu200, specifically Ser167, Thr169, and residues at the N- and C-termini of the loop are highly conserved across the same Dio types with significant variation in the middle sequence of the Ω-loop. Hydrogen bonding around Glu200 fixes the early sequence of the loop to the active site and limits its conformation dynamics. Previous experimental mutation studies of residues involved in this anchor region lead to inactive proteins. Disruption of hydrogen bonds anchored at Glu200 by mutation of key residues (e.g., Ser167Ala, Glu200Ala, Thr169Ala) likely allow too much flexibility for the formation of the key loop conformation which prevents substrate binding or alignment of a previously proposed proton transfer pathway.
The highly conserved Trp207 appears to drive the conformation dynamics of the Ω-loop. Folding of Trp207 into a nonpolar cleft correctly positions the loop to reinforce the I⋯O halogen bond between an outer-ring TH iodine and the carboxylate side chain of Asp211. This residue is conserved only in Dio3 where it is required for the IRD regioselectivity of Dio3. The sequence and length of the Ω-loop between Trp207 and His219 varies significantly between Dio1-3, but with high similarity within types. These variations likely contribute to regioselectivity by allowing type-specific conformations capable of orienting a TH for IRD or ORD. The conserved Trp207 may control loop conformation for regioselective deiodination. Given that the interpretations of the MD simulations of the apo- and T4-Dio3 proteins are consistent with previous mutation studies of key residues (e.g., Glu200, His219, etc.), new mutation studies may confirm the importance of Trp207 and Asp211. Additionally, comparative MD simulations of Dio1 and Dio2 will determine how the conformational preferences of different loop sequences contribute to regioselective TH binding, which may lead to the design of inhibitors tailored to specific Dio types to treat TH-related illnesses.
The protein model was modified from the X-ray structure of the catalytic region of mus Dio3 (PDB: 4TR4; residues 114–301) by removing the linker region (residues Gly114 to Gly131) to the membrane-bound domain and capping the N-terminus with an acetyl group (Dio3trunc). Hydrogens were added to the X-ray structure using the H++ server55. Dio3trunc was modelled as the monomer because the homodimer structure has not been characterized experimentally. Alternate possible dimerization interfaces have been proposed14,56. In simulations of the full 4TR4 protein, the N-terminal linker sequence wrapped around the protein to interact with the Ω-loop. This tendency may contribute to the experimental inactivity of the monomeric catalytic region14 if representative of the solution behaviour of the protein. Sec170, located in the α1β1 turn and facing a region bounded by the β2αD, α2β3, and β4α3 loops, is deprotonated at physiological pH57. The model assumes that its proton is transferred to nearby His202 to increase Sec nucleophilicity as observed in other selenoproteins47.
Normal mode analysis was performed using the anisotropic and Gaussian network models (ANM and GNM, respectively) within the ProDy open-source package (see Supporting Information)58 MD simulations were performed using the PMEDA GPU routines in AMBER 1659. The protein was represented with the ff99sb force field. Parameters for Sec were modified from the deprotonated Cys force field using charges, bond distances and force constants derived from DFT calculations. T4 was roughly docked to conformations A–C using AutoDock Vina60. The T4 force field was derived using ANTECHAMBER. The T4-Dio3trunc model assumes a strong I⋯Se XB interaction between an inner-ring iodine and the Sec residue dominated by bonding character18,19. Charges for the XB T4 and the I⋯Se and force constant were obtained from DFT calculations of the T4–MeSe− complex24. The remaining iodines use the method of Jorgensen and Schyman to mimic the σ-hole using a positively charged dummy atom38. The protein models were solvated with a 10 Å octahedral box of TIP3P water. Bond lengths to hydrogen atoms were constrained using SHAKE. Systems were initially warmed and equilibrated to 300 K using Langevin dynamics in the NVT ensemble. Systems were then equilibrated in the NPT ensemble prior to multi-μs production simulations. Statistical analysis of the trajectories is described in Supporting Information32,33. Electrostatic surfaces were generated by the Adaptive Poisson–Boltzman Solver within the PyMol graphical user interface (version 1.10.10)61. Additional images were created using VMD version 1.9.362.
The apo-Dio3trunc trajectory was stripped of solvent and hydrogens for processing using the TimeScapes package of python routines for statistical analysis of MD trajectories32,33,63. This methodology differs from the traditional RMSD (Fig S1a) in that a course-grained model is imposed on the trajectory which is then analysed in terms of side chain motions rather than Cα. Rates of pairwise contact and hinge-pivot events were determined based upon (a) cutoff distances and (b) generalized masked Delaunay (GMD) tetrahedralization of representative atoms of the course-grained protein and counted subject to the requirement of crossing a buffer region defined either in terms of a cutoff distance or the GMD order. The dependence on pairwise contacts and backbone motions was determined using both Pearson cross-correlation and mutual information approaches. The Dio3trunc trajectory was culled to 2000 snapshots by extracting frames at 100 ns intervals. The RMS fluctuation of the Cartesian coordinates was first determined using a sliding window of 10 frames with least-squares fitting to the X-ray structure. Analysis of the Dio3trunc trajectory applied a cutoff buffer of 6.0–8.5 Å and a GMD buffer between graphs of orders 2 and 3 (Fig. S2).
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J. & Larsen, P. R. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 23, 38–89 (2002).
Köhrle, J. Iodothyronine deiodinases. In Methods in Enzymology (eds Sies, H. & Packer, L.) 125–167 (Academic Press, Cambridge, 2002).
Mondal, S., Raja, K., Schweizer, U. & Mugesh, G. Chemistry and biology in the biosynthesis and action of thyroid hormones. Angew. Chem. Int. Ed. 55, 7606–7630 (2016).
Schweizer, U., Towell, H., Vit, A., Rodriguez-Ruiz, A. & Steegborn, C. Structural aspects of thyroid hormone binding to proteins and competitive interactions with natural and synthetic compounds. Mol. Cell. Endocrinol. 458, 57–67 (2017).
van der Spek, A. H., Fliers, E. & Boelen, A. The classic pathways of thyroid hormone metabolism. Mol. Cell. Endocrinol. 458, 29–38 (2017).
Bianco, A. C. & Kim, B. W. Deiodinases: implications of the local control of thyroid hormone action. J. Clin. Invest. 116, 2571–2579 (2006).
Darras, V. M. & Herck, S. L. J. V. Iodothyronine deiodinase structure and function: from ascidians to humans. J. Endocrinol. 215, 189–206 (2012).
Luongo, C., Dentice, M. & Salvatore, D. Deiodinases and their intricate role in thyroid hormone homeostasis. Nat. Rev. Endocrinol. 15, 479–488 (2019).
Kuiper, G., Kester, M. H. A., Peeters, R. P. & Visser, T. J. Biochemical mechanisms of thyroid hormone deiodination. Thyroid 15, 787–798 (2005).
Steegborn, C. & Schweizer, U. Structure and mechanism of iodothyronine deiodinases: what we know, what we don’t know, and what would be nice to know. Exp. Clin. Endocrinol. Diabetes. 128, 375–378 (2020).
Liu, X., Guo, Z., Sun, H., Li, W. & Sun, W. Comprehensive map and functional annotation of human pituitary and thyroid proteome. J. Proteome Res. 16, 2680–2691 (2017).
Jarque, S. & Piña, B. Deiodinases and thyroid metabolism disruption in teleost fish. Environ. Res. 135, 361–375 (2014).
Carpenter, E. P., Beis, K., Cameron, A. D. & Iwata, S. Overcoming the challenges of membrane protein crystallography. Curr. Opin. Struct. Biol. 18, 581–586 (2008).
Schweizer, U., Schlicker, C., Braun, D., Köhrle, J. & Steegborn, C. Crystal structure of mammalian selenocysteine-dependent iodothyronine deiodinase suggests a peroxiredoxin-like catalytic mechanism. Proc. Natl. Acad. Sci. 111, 10526–10531 (2014).
Callebaut, I. et al. The iodothyronine selenodeiodinases are thioredoxin-fold family proteins containing a glycoside hydrolase clan GH-A-like structure. J. Biol. Chem. 278, 36887–36896 (2003).
Berry, M., Kieffer, J., Harney, J. & Larsen, P. Selenocysteine confers the biochemical-properties characteristic of the type-I iodothyronine deiodinase. J. Biol. Chem. 266, 14155–14158 (1991).
Fomenko, D. E. & Gladyshev, V. N. Identity and functions of CxxC-derived motifs. Biochemistry 42, 11214–11225 (2003).
Bayse, C. A. & Rafferty, E. R. Is halogen bonding the basis for iodothyronine deiodinase activity?. Inorg. Chem. 49, 5365–5367 (2010).
Bayse, C. A. Halogen bonding from the bonding perspective with considerations for mechanisms of thyroid hormone activation and inhibition. New J. Chem. 42, 10623–10632 (2018).
Manna, D. & Mugesh, G. A chemical model for the inner-ring deiodination of thyroxine by iodothyronine deiodinase. Angew. Chem. 122, 9432–9435 (2010).
Manna, D. & Mugesh, G. Regioselective deiodination of thyroxine by iodothyronine deiodinase mimics: an unusual mechanistic pathway involving cooperative chalcogen and halogen bonding. J. Am. Chem. Soc. 134, 4269–4279 (2012).
Cesario, D. et al. The role of the halogen bond in iodothyronine deiodinase: dependence on chalcogen substitution in naphthyl-based mimetics. J. Comput. Chem. 40, 944–951 (2019).
Visser, T. J., Kaptein, E., Terpstra, O. T. & Krenning, E. P. Deiodination of thyroid hormone by human liver. J. Clin. Endocrinol. Metab. 67, 17–24 (1988).
Marsan, E. S. & Bayse, C. A. Halogen-bonding interactions of polybrominated diphenyl ethers and thyroid hormone derivatives: a potential mechanism for the inhibition of iodothyronine deiodinase. Chem. Eur. J. 23, 6625–6633 (2017).
Marsan, E. S. & Bayse, C. A. Halogen bonding interactions of polychlorinated biphenyls and the potential for thyroid disruption. Chem. Eur. J. 26, 5200–5207 (2020).
Marsan, E. S. & Bayse, C. A. A halogen bonding perspective on iodothyronine deiodinase activity. Molecules 25, 1328 (2020).
Manna, D., Mondal, S. & Mugesh, G. Halogen bonding controls the regioselectivity of the deiodination of thyroid hormones and their sulfate analogues. Chem. Eur. J. 21, 2409–2416 (2015).
Fetrow, J. S. Omega loops: nonregular secondary structures significant in protein function and stability. FASEB J. 9, 708–717 (1995).
Pal, M. & Dasgupta, S. The nature of the turn in omega loops of proteins. Proteins Struct. Funct. Bioinform. 51, 591–606 (2003).
Leszczynski, J. & Rose, G. Loops in globular proteins: a novel category of secondary structure. Science 234, 849–855 (1986).
Wako, H. & Endo, S. Normal mode analysis as a method to derive protein dynamics information from the protein data bank. Biophys. Rev. 9, 877–893 (2017).
Wriggers, W. et al. Automated event detection and activity monitoring in long molecular dynamics simulations. J. Chem. Theory Comput. 5, 2595–2605 (2009).
Kovacs, J. A. & Wriggers, W. Spatial heat maps from fast information matching of fast and slow degrees of freedom: application to molecular dynamics simulations. J. Phys. Chem. B 120, 8473–8484 (2016).
Gu, Y., Li, D.-W. & Brüschweiler, R. Decoding the mobility and time scales of protein loops. J. Chem. Theory Comput. 11, 1308–1314 (2015).
Gu, Y., Li, D.-W. & Brüschweiler, R. Statistical database analysis of the role of loop dynamics for protein–protein complex formation and allostery. Bioinformatics 33, 1814–1819 (2017).
Schweizer, U. & Steegborn, C. New insights into the structure and mechanism of iodothyronine deiodinases. J. Mol. Endocrinol. 55, 37–52 (2015).
Bui, J. M., Tai, K. & McCammon, J. A. Acetylcholinesterase: enhanced fluctuations and alternative routes to the active site in the complex with fasciculin-2. J. Am. Chem. Soc. 126, 7198–7205 (2004).
Jorgensen, W. L. & Schyman, P. Treatment of halogen bonding in the OPLS-AA force field: application to potent anti-HIV agents. J. Chem. Theory Comput. 8, 3895–3901 (2012).
Cavallo, G. et al. The halogen bond. Chem. Rev. 116, 2478–2601 (2016).
Wilcken, R., Zimmermann, M. O., Lange, A., Joerger, A. C. & Boeckler, F. M. Principles and applications of halogen bonding in medicinal chemistry and chemical biology. J. Med. Chem. 56, 1363–1388 (2013).
Sirimulla, S., Bailey, J. B., Vegesna, R. & Narayan, M. Halogen interactions in protein–ligand complexes: implications of halogen bonding for rational drug design. J. Chem. Inf. Model. 53, 2781–2791 (2013).
Berry, R. E. et al. Axial ligand complexes of the Rhodnius nitrophorins: reduction potentials, binding constants, EPR spectra, and structures of the 4-iodopyrazole and imidazole complexes of NP4. JBIC J. Biol. Inorg. Chem. 9, 135–144 (2004).
Ghuman, J. et al. Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 353, 38–52 (2005).
Köhrle, J. Local activation and inactivation of thyroid hormones: the deiodinase family. Mol. Cell. Endocrinol. 151, 103–119 (1999).
Berry, M. J. Identification of essential histidine residues in rat type I iodothyronine deiodinase. J. Biol. Chem. 267, 18055–18059 (1992).
Nascimento, A. S. et al. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function. J. Mol. Biol. 360, 586–598 (2006).
Roy, G., Sarma, B. K., Phadnis, P. P. & Mugesh, G. Selenium-containing enzymes in mammals: chemical perspectives. J. Chem. Sci. 117, 287–303 (2005).
Koh, C. S. et al. Crystal structures of a poplar thioredoxin peroxidase that exhibits the structure of glutathione peroxidases: insights into redox-driven conformational changes. J. Mol. Biol. 370, 512–529 (2007).
Hall, A., Parsonage, D., Poole, L. B. & Karplus, P. A. Structural evidence that peroxiredoxin catalytic power is based on transition-state stabilization. J. Mol. Biol. 402, 194–209 (2010).
Edeling, M. A., Guddat, L. W., Fabianek, R. A., Thöny-Meyer, L. & Martin, J. L. Structure of CcmG/DsbE at 1.14 Å resolution: high-fidelity reducing activity in an indiscriminately oxidizing environment. Structure 10, 973–979 (2002).
Copley, S. D., Novak, W. R. P. & Babbitt, P. C. Divergence of function in the thioredoxin fold suprafamily: evidence for evolution of peroxiredoxins from a thioredoxin-like ancestor. Biochemistry 43, 13981–13995 (2004).
Ferguson, A. D. et al. NMR structures of the selenoproteins Sep15 and SelM reveal redox activity of a new thioredoxin-like family. J. Biol. Chem. 281, 3536–3543 (2006).
Arrojo e Drigo, R., Fonseca, T. L., Werneck-de-Castro, J. P. S. & Bianco, A. C. Role of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signaling. Biochim. Biophys. Acta BBA 1830, 3956–3964 (2013).
Gereben, B., Goncalves, C., Harney, J. W., Larsen, P. R. & Bianco, A. C. Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation. Mol. Endocrinol. 14, 1697–1708 (2000).
Anandakrishnan, R., Aguilar, B. & Onufriev, A. V. H++ 30: automating pK prediction and the preparation of biomolecular structures for atomistic molecular modeling and simulations. Nucleic Acids Res. 40, W537–W541 (2012).
Sagar, G. D. V. et al. The thyroid hormone-inactivating deiodinase functions as a homodimer. Mol. Endocrinol. 22, 1382–1393 (2008).
Lu, J. & Holmgren, A. Selenoproteins. J. Biol. Chem. 284, 723–727 (2009).
Bakan, A., Meireles, L. M. & Bahar, I. ProDy: protein dynamics inferred from theory and experiments. Bioinformatics 27, 1575–1577 (2011).
Case, D. A. et al. AMBER 16. https://ambermd.org/ (2016).
Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455–461 (2010).
DeLano, W.L. PyMol Molecular Graphics System. https://pymol.org/ (Schrodinger, Inc., 2015).
Humphrey, W., Dalke, A. & Schulten, K. V. M. D. Visual molecular dynamics. J. Mol. Graph. 14, 33–38 (1996).
Wriggers, W. TimeScapes Analytics Package. https://timescapes.biomachina.org/ (2017).
This research was funded by the National Institutes of Health (R15 GM119063-01A1). All calculations were performed on the Turing High Performance Cluster maintained by ODU Information Technology Services.
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Bayse, C.A., Marsan, E.S., Garcia, J.R. et al. Thyroxine binding to type III iodothyronine deiodinase. Sci Rep 10, 15401 (2020). https://doi.org/10.1038/s41598-020-72243-9